Abe K, Nicholson W E, Liddle G W, Island D P, Orth D N
J Clin Invest. 1967 Oct;46(10):1609-16. doi: 10.1172/JCI105653.
A radioimmunoassay method for beta-melanocyte-stimulating hormone (beta-MSH) has been developed and utilized in the identification and quantification of this hormone in human plasma and tissues. The concentration of beta-MSH in two human pituitary glands was found to be approximately 350 mug/g. beta-MSH was identified in the tumor tissue of all 11 patients with the ectopic ACTH syndrome who were studied; concentrations in individual cases ranged from 3 to 1600 ng/g. In plasma of chronically hyperpigmented patients with Addison's disease, Cushing's disease (after bilateral adrenalectomy), and the ectopic ACTH syndrome, beta-MSH concentrations of 0.5-6 ng/ml were found. The degree of clinical hyperpigmentation was well correlated with the quantity of beta-MSH in the plasma. beta-MSH concentrations in the plasma of normal subjects were less than 0.09 ng/ml. In all of these circumstances, bioassays for MSH were also performed, and it was found that most of the biologic MSH activity of the plasma and tissues could be accounted for by beta-MSH.
已开发出一种用于检测β-促黑素细胞激素(β-MSH)的放射免疫测定方法,并用于鉴定和定量人血浆及组织中的这种激素。发现两个人垂体中β-MSH的浓度约为350微克/克。在所研究的11例异位促肾上腺皮质激素(ACTH)综合征患者的肿瘤组织中均鉴定出β-MSH;个别病例中的浓度范围为3至1600纳克/克。在患有艾迪生病、库欣病(双侧肾上腺切除术后)和异位ACTH综合征的慢性色素沉着患者的血浆中,发现β-MSH浓度为0.5至6纳克/毫升。临床色素沉着程度与血浆中β-MSH的量密切相关。正常受试者血浆中的β-MSH浓度低于0.09纳克/毫升。在所有这些情况下,还进行了MSH的生物测定,发现血浆和组织中的大多数生物MSH活性可由β-MSH解释。